Top

Published in:

01-12-2016 | Head and Neck Oncology

Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy

Authors: Jae-Keun Cho, MD, Byung-Woo Lim, MD, Eun-Hye Kim, RN, Young-Hyeh Ko, MD, PhD, Dongryul Oh, MD, Jae-Myoung Noh, MD, Yong Chan Ahn, MD, PhD, Kwan-Hyuck Baek, PhD, Han-Sin Jeong, MD, PhD

Published in: Annals of Surgical Oncology | Issue 13/2016

Abstract

Background

Histologic grade of tumor is one of the major prognostic predictors for patients with salivary gland cancer. Because of disease rarity, little is known about the optimal treatment modalities and outcomes in low-grade salivary gland cancers (LGSGC). We tried to identify prognostic factors, and the adequate treatment modalities and outcomes in pathologically confirmed LGSGC patients.

Methods

We retrospectively extracted the clinical and pathology data from 179 LGSGC cases from 1995 to 2013. Pathological features, such as extraparenchymal extension, perineural/nerve invasion, lymphovascular invasion/tumor emboli, and resection margin status were redefined for each case. Risk factors for recurrence, extent of surgery, and the role of postoperative radiation therapy were analyzed.

Results

Recurrence-free survival and overall survival were 89.6 and 96.6 % at 10 years, respectively. The presence of regional nodal metastasis and positive cancer cells at resection margin were significant unfavorable prognostic factors. Postoperative adjuvant radiation treatment significantly reduced recurrences, particularly in cases with pathology risk factors (perineural invasion, lymphovascular invasion, extraparenchymal extension, or cancer cells at the resection margin), node metastasis, and advanced T-stage tumors. Close surgical margin <5 mm was not a significant risk factor for recurrence, and less-than-total resection of the affected gland did not increase recurrence, if surgery could achieve a cancer cell-free surgical margin.

Conclusion

Postoperative radiation clearly benefitted patients with pathology risk factors, node metastasis, and advanced T stage in LGSGC. Meanwhile, the oncological outcomes are very good with surgery alone in cases of pT1-2N0 LGSGC without pathology risk factors.

Available only for authorised users

Huang AT, Tang C, Bell D, et al. Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015;51:610–5.CrossRefPubMed

Adelstein DJ, Koyfman SA, El-Naggar AK, Hanna EY. Biology and management of salivary gland cancers. Semin Radiat Oncol. 2012;22:245–53.CrossRefPubMed

Tumours of the salivary glands. In: Barnes L, Everson JW, Reichart P, Sidransky D (eds). World Health Organization classification of tumors: pathology and genetics: head and neck tumors. Lyon: IARC Press; 2005. p. 209–81.

Brandwein MS, Ferlito A, Bradley PJ, Hille JJ, Rinaldo A. Diagnosis and classification of salivary neoplasms: pathologic challenges and relevance to clinical outcomes. Acta Otolaryngol. 2002;122:758–64.CrossRefPubMed

Seifert G, Sobin LH. The World Health Organization’s histological classification of salivary gland tumors. A commentary on the second edition. Cancer. 1992;70:379–85.CrossRefPubMed

Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg. 2005;133:702–8.CrossRefPubMed

Bell RB, Dierks EJ, Homer L, Potter BE. Management and outcome of patients with malignant salivary gland tumors. J Oral Maxillofac Surg. 2005;63:917–28.CrossRefPubMed

Walvekar RR, Andrade Filho PA, Seethala RR, et al. Clinicopathologic features as stronger prognostic factors than histology or grade in risk stratification of primary parotid malignancies. Head Neck. 2011;33:225–31.CrossRefPubMedPubMedCentral

McHugh CH, Roberts DB, El-Naggar AK, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012;118:3928–36.CrossRefPubMed

10.

Jegadeesh N, Liu Y, Prabhu RS, et al. Outcomes and prognostic factors in modern era management of major salivary gland cancer. Oral Oncol. 2015;51:770–7.CrossRefPubMedPubMedCentral

11.

Richter SM, Friedmann P, Mourad WF, Hu KS, Persky MS, Harrison LB. Postoperative radiation therapy for small, low-/intermediate-grade parotid tumors with close and/or positive surgical margins. Head Neck. 2012;34:953–5.CrossRefPubMed

12.

Garden AS, el-Naggar AK, Morrison WH, Callender DL, Ang KK, Peters LJ. Postoperative radiotherapy for malignant tumors of the parotid gland. Int J Radiat Oncol Biol Phys. 1997;37:79–85.

13.

Gomez DR, Katabi N, Zhung J, et al. Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland. Cancer. 2009;115:2128–37.CrossRefPubMed

14.

Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck. 2004;26:681–92. discussion 92–3.CrossRefPubMed

15.

Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.CrossRefPubMed

16.

Batsakis JG, Luna MA. Histopathologic grading of salivary gland neoplasms: I. Mucoepidermoid carcinomas. Ann Otol Rhinol Laryngol. 1990;99:835–8.CrossRefPubMed

17.

Nance MA, Seethala RR, Wang Y, et al. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer. 2008;113:2082–9.CrossRefPubMedPubMedCentral

18.

Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer. 1984;54:1062–9.CrossRefPubMed

19.

Seethala RR. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009;3:69–77.CrossRefPubMedPubMedCentral

20.

Noh JM, Ahn YC, Nam H, et al. Treatment results of major salivary gland cancer by surgery with or without postoperative radiation therapy. Clin Exp Otorhinolaryngol. 2010;3:96–101.CrossRefPubMedPubMedCentral

21.

Haderlein M, Scherl C, Semrau S, et al. High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype. Head Neck. 2016;38 Suppl 1:E2041–8.CrossRefPubMed

22.

Kim BY, Hyeon J, Ryu G, et al. Diagnostic accuracy of fine needle aspiration cytology for high-grade salivary gland tumors. Ann Surg Oncol. 2013;20:2380–7.CrossRefPubMed

23.

Jeong HS, Chung MK, Son YI, et al. Role of 18F-FDG PET/CT in management of high-grade salivary gland malignancies. J Nucl Med. 2007;48:1237–44.CrossRefPubMed

Title: Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy
Authors: Jae-Keun Cho, MD
Byung-Woo Lim, MD
Eun-Hye Kim, RN
Young-Hyeh Ko, MD, PhD
Dongryul Oh, MD
Jae-Myoung Noh, MD
Yong Chan Ahn, MD, PhD
Kwan-Hyuck Baek, PhD
Han-Sin Jeong, MD, PhD
Publication date: 01-12-2016
Publisher: Springer International Publishing
Published in: Annals of Surgical Oncology / Issue 13/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/s10434-016-5353-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 13/2016

Pylorus-Preserving Surgery Based on the Sentinel Node Concept in Early Gastric Cancer

Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma

Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer

Adjuvant Chemotherapy: What’s the Rush?

A Choice of Wine

Advanced Pseudomyxoma Peritonei Requiring Gastrectomy to Achieve Complete Cytoreduction Results in Good Long-Term Oncologic Outcomes